Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harsimrat Kaur Birdi"'
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy
Autor:
Fanny Tzelepis, Harsimrat Kaur Birdi, Anna Jirovec, Silvia Boscardin, Christiano Tanese de Souza, Mohsen Hooshyar, Andrew Chen, Keara Sutherland, Robin J. Parks, Joel Werier, Jean-Simon Diallo
Publikováno v:
Molecular Therapy: Oncolytics, Vol 19, Iss , Pp 240-252 (2020)
Prime-boost vaccination employing heterologous viral vectors encoding an antigen is an effective strategy to maximize the antigen-specific immune response. Replication-deficient adenovirus serotype 5 (Ad5) is currently being evaluated clinically in N
Externí odkaz:
https://doaj.org/article/85c0f1ffc30c4c7e93249fbf227e89f3
Autor:
Carolyn Nessim, Jean-Simon Diallo, Harsimrat Kaur Birdi, Anna Jirovec, Serena Cortés-Kaplan, Joel Werier, Michele Ardolino
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Sarcomas are a rare malignancy of mesenchymal tissues, comprizing a plethora of unique subtypes, with more than 60 types. The sheer heterogeneity of disease phenotype makes this a particularly difficult cancer to treat. Radiotherapy, chemotherapy and
Externí odkaz:
https://doaj.org/article/e1fe72d8937549b89ab948186d980f96
Autor:
Anabel Bergeron, Vanessa Garcia, Rozanne Arulanandam, Fanny Tzelepis, Jean-Simon Diallo, Harsimrat Kaur Birdi, Anne Landry, Andrew Chen, Anna Jirovec, Oliver Varette, Keara Sutherland, Mohammed Selman, Zaid Taha, Nouf Alluqmani, Elizabeth Macdonald, Barbara C. Vanderhyden
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-10 (2020)
Communications Biology
Communications Biology
We have demonstrated that microtubule destabilizing agents (MDAs) can sensitize tumors to oncolytic vesicular stomatitis virus (VSVΔ51) in various preclinical models of cancer. The clinically approved T-DM1 (Kadcyla®) is an antibody-drug conjugate
Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy
Autor:
Robin J. Parks, Mohsen Hooshyar, Silvia Beatriz Boscardin, Fanny Tzelepis, Keara Sutherland, Harsimrat Kaur Birdi, Joel Werier, Jean-Simon Diallo, Andrew Chen, Anna Jirovec, Christiano Tanese de Souza
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Molecular Therapy: Oncolytics, Vol 19, Iss, Pp 240-252 (2020)
Molecular Therapy Oncolytics
Universidade de São Paulo (USP)
instacron:USP
Molecular Therapy: Oncolytics, Vol 19, Iss, Pp 240-252 (2020)
Molecular Therapy Oncolytics
Prime-boost vaccination employing heterologous viral vectors encoding an antigen is an effective strategy to maximize the antigen-specific immune response. Replication-deficient adenovirus serotype 5 (Ad5) is currently being evaluated clinically in N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d0fd8e44f5714ec9ec9da4d8144005
Autor:
Harsimrat Kaur Birdi, Carolyn Nessim, Jean-Simon Diallo, Joel Werier, Serena Cortés-Kaplan, Anna Jirovec, Michele Ardolino
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Sarcomas are a rare malignancy of mesenchymal tissues, comprizing a plethora of unique subtypes, with more than 60 types. The sheer heterogeneity of disease phenotype makes this a particularly difficult cancer to treat. Radiotherapy, chemotherapy and
Autor:
Carolyn Nessim, Jean-Simon Diallo, Harsimrat Kaur Birdi, Anna Jirovec, Serena Cortés-Kaplan, Joel Werier, Michele Ardolino
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)